Three-Pore Model Predictions of 24-Hour Automated Peritoneal Dialysis Therapy Using Bimodal Solutions

2011 ◽  
Vol 31 (5) ◽  
pp. 537-544 ◽  
Author(s):  
Alp Akonur ◽  
J. Ken Leypoldt

BackgroundRecently, bimodal peritoneal dialysis (PD) solutions containing low concentrations of Na have been shown to increase 24-hour ultrafiltration (UF) or UF efficiency (UF volume per gram of carbohydrate or CHO absorbed) and Na removal in high (“fast”) transport patients during automated PD therapy. We used computer simulations to compare UF efficiency and Na removal at equivalent 24-hour UF volumes using either a generic bimodal solution (2.27% glucose + 7.5% icodextrin) during the long dwell or an increase in the glucose concentration during the short dwells, with all solutions containing Na at the conventional concentration (132 mEq/L).MethodsThe 3-pore model has been shown to accurately predict peritoneal transport for PD solutions containing glucose or icodextrin, or both. Here, we used that model to calculate 24-hour UF volume, CHO absorption, and Na removal for high (H), high-average (HA), and low-average (LA) transport patients on automated PD. Nighttime therapy consisted of 1.36% or 2.27% glucose solution (or both), and daytime therapy consisted of either Extraneal (Baxter Healthcare Corporation, Deerfield, IL, USA) or a bimodal solution.ResultsAs expected, addition of glucose to either the long dwell or the short dwells resulted in increased UF volume and glucose absorption. The increase in UF was a function of patient transport type (bimodal range: 288 – 490 mL; short-dwell range: 323 – 350 mL), and the increase in CHO absorption was smaller with glucose added to short dwells than with bimodal solution (range: 18 – 30 g vs. 34 – 39 g). The 24-hour UF efficiency was higher when high glucose concentrations were used during short-dwell exchanges than when a bimodal PD solution was used for the long dwell (0.6 to 1.2 mL/g vs. –0.1 to 0.5 mL/g). By contrast, Na removal was lower with the short-dwell exchanges (28.3 – 30.7 mmol vs. 36.2 – 53.3 mmol), likely because of more pronounced Na sieving.ConclusionsOur modeling studies predict that generic bimodal PD solutions will provide higher Na removal but not higher 24-hour UF efficiency compared with current automated PD prescriptions using Extraneal for the long dwell and glucose-containing solutions for the short dwells. The modeling predictions from this study require clinical validation.

2021 ◽  
pp. 089686082110100
Author(s):  
Carl M Öberg

Background: Previous studies suggested that automated peritoneal dialysis (APD) could be improved in terms of shorter treatment times and lower glucose absorption using bimodal treatment regimens, having ‘ultrafiltration (UF) cycles’ using a high glucose concentration and ‘clearance cycles’ using low or no glucose. The purpose of this study is to explore such regimes further using mathematical optimization techniques based on the three-pore model. Methods: A linear model with constraints is applied to find the shortest possible treatment time given a set of clinical treatment goals. For bimodal regimes, an exact analytical solution often exists which is herein used to construct optimal regimes giving the same Kt/ V urea and/or weekly creatinine clearance and UF as a 6 × 2 L 1.36% glucose regime and an ‘adapted’ (2 × 1.5 L 1.36% + 3 × 3 L 1.36%) regime. Results: Compared to the non-optimized (standard and adapted regimes), the optimized regimens demonstrated marked reductions (>40%) in glucose absorption while having an identical weekly creatinine clearance (35 L) and UF (0.5 L). Larger fill volumes of 1200 mL/m2 (UF cycles) and 1400 mL/m2 (clearance cycles) can be used to shorten the total treatment time. Conclusion: These theoretical results imply substantial improvements in glucose absorption using optimized APD regimens while achieving similar water and solute removal as non-optimized APD regimens. While the current results are based on a well-established theoretical model for peritoneal dialysis, experimental and clinical studies need to be performed to validate the current findings.


2019 ◽  
Vol 109 ◽  
pp. 1327-1338 ◽  
Author(s):  
Ying Zhou ◽  
Jinjin Fan ◽  
Chenfei Zheng ◽  
Peiran Yin ◽  
Haishan Wu ◽  
...  

2020 ◽  
Vol 123 (11) ◽  
pp. 1269-1276
Author(s):  
Steven Law ◽  
Andrew Davenport

AbstractThe majority of peritoneal dialysates use glucose to generate an osmotic gradient for the convective removal of water and Na. Although glucose can potentially be absorbed, previous studies have failed to establish whether this leads to increased fat weight gain. We measured body composition using bioimpedance in peritoneal dialysis (PD) patients, electively starting PD, attending for their first assessment of peritoneal membrane function after 2–3 months, and then after 12 months. We studied 143 patients: eighty-nine (62·2 %) males, fifty-three (37·1 %) diabetics, mean age 61·3 (SD 14·9) years, with ninety (62·1 %) patients treated by automated PD cyclers with a daytime icodextrin exchange and thirty-seven (25·9 %) by continuous ambulatory PD. Median fat mass increased by 1·8 (–0·5 to 4·1) kg, whereas fat-free mass fell –1·3 (–2·9 to 1·0) kg, and the increase in fat mass was negatively associated with the fall in soft lean mass (r –0·41, P < 0·001). Increased fat mass was associated with measured peritoneal glucose absorption (r 0·69, P < 0·001), and glucose absorption was associated with the amount of 22·7 g/l glucose dialysate (OR 2·0, 95 % CI 1·5, 2·5, P < 0·001), peritoneal urea clearance (OR 9·5, 95 % CI 2·4, 37·1, P = 0·001) and male sex (OR 4·8, 95 % CI 1·5, 14·9, P = 0·008). We report an observational study in prevalent PD patients following body composition from their first assessment of PD membrane function for approximately 12 months, and despite the majority of patients prescribed icodextrin, we have demonstrated not only an association between intra-peritoneal glucose absorption and fat weight gain but also loss of fat-free mass.


2019 ◽  
Vol 48 (1) ◽  
pp. 25-31 ◽  
Author(s):  
Sana F. Khan ◽  
Claudio Ronco ◽  
Mitchell H. Rosner

Glucose-based peritoneal dialysis (PD) solutions are the predominantly used dialysate in PD patients. Glucose absorption has been shown to be associated with several unfavorable metabolic complications. Several studies have shown positive effects of exercise in end-stage renal disease patients. This paper provides an overview of glucose-associated metabolic complications, and proposed exercise regimens to counteract the caloric load associated with glucose absorption.


1993 ◽  
Vol 13 (2_suppl) ◽  
pp. 67-69 ◽  
Author(s):  
Luis G. Burdiel ◽  
Antonio Jiménez ◽  
Alejandro Martin-Malo ◽  
Domingo Castillo ◽  
Mariano Rodriguez ◽  
...  

The osmotic gradient is the main driving force for ultrafiltration (UF) in continuous ambulatory peritoneal dialysis (CAPD). Depending on glucose absorption, its changes over a period of time could influence the plasma refilling rate. The aim of this study was to evaluate the Influence of changes In the plasma refilling rate obtained by dlalysates of different osmolalities upon the rate of UF. Stable CAPD patients were studied twice during a 4-hour exchange 2 weeks apart with dialysate containing 1.5% and 4.25% glucose, respectively. UF was estimated by the autologous hemoglobin dilution method every 30 minutes. Hematocrit and colloidosmotic pressure (COP) decraase when using 1.5% glucose dialysate, reflecting a rise In plasma water mediated by the plasma refilling rate. This water shift Is greater than the osmotic gradient generated between peritoneal and intravascular compartments as reflected by a low UF rate. However, when the osmotic gradient Increases by means of 4.25% glucose dialysate, the plasma refilling rate is efficiently counterbalanced by UF.


1989 ◽  
Vol 9 (1) ◽  
pp. 75-78 ◽  
Author(s):  
Min Sun Park ◽  
Jean Lee ◽  
Moon Sung Lee ◽  
Seung Ho Baick ◽  
Seung Duk Hwang ◽  
...  

In order to evaluate peritoneal membrane function and responsiveness of peritoneal microcirculation to vasoactive agents in long-term continuous ambulatory peritoneal dialysis (CAPD) patients, we studied peritoneal clearances of urea (Curea) and creatinine (Ccr), protein concentrations in drained dialysate (D PC), peritoneal glucose absorption (% GA), and drained dialysate volume ( VD) before and after nitroprusside (NP) addition to dialysis solution in 17 long-term CAPD patients (mean duration of CAPD: 52 months) and the results were compared to those of 18 patients who were just trained for CAPD (mean duration: 0.6 month). There were no differences in the control (without NP) Curea, Ccr, D PC, %GA, and VD between the new and long-term CAPD patients. Curea, Ccr, and D PC increased significantly with NP in both new and long-term patients. Curea and Ccr with NP were not different between the new and long-term patients but D PC with NP was significantly lower in the long-term CAPD patients. The results of this study suggest that peritoneal solute clearances and the responsiveness of peritoneal microcirculation to NP remain unchanged after four years of CAPD, despite recurrent episodes of peritonitis.


1979 ◽  
Vol 236 (2) ◽  
pp. E198
Author(s):  
J D Valleau ◽  
D N Granger ◽  
A E Taylor

The effects of solute-coupled volume absorption on blood flow, oxygen consumption, and vascular resistance were analyzed in autoperfused segments of cat ileum. Intestinal absorption was stimulated by placing either Tyrode solution, Tyrode + glucose, or Tyrode + taurocholate into the ileal lumen. Net volume absorption rates (Jv,m) were determined using a volume recovery method. Oxygen consumption (VO2) increased during the absorption of all solutions. The absorption of Tyrode solution plus glucose caused the greatest increase in VO2, whereas Tyrode plus taurocholate resulted in the smallest increase. For Tyrode solution and Tyrode plus glucose absorption, the increased VO2 was due predominantly to an increased blood flow, whereas the increased VO2 with taurocholate resulted from an increased oxygen extraction. A linear relationship between the change in VO2 during transport and Jv,m was aquired for Tyrode solution, and Tyrode + glucose. The results indicate that the oxygen requirements of the absorbing intestine are dependent on both the rate of transport and the solutes being transported.


1989 ◽  
Vol 9 (3) ◽  
pp. 175-178 ◽  
Author(s):  
Richard Swartz ◽  
Janice Reynolds ◽  
Patricia Lees ◽  
Leslie Rocher

Disadvantages of continuous ambulatory peritoneal dialysis (CAPD), such as inconvenience and bulkiness of the apparatus, inflexibility of infusion volume, and predictable peritonitis incidence may be altered by using systems which allow disconnection from the tubing and bag after each exchange. At University of Michigan we have followed 35 patients using the O set@ with sodium hypochlorite (Baxter Healthcare Corp.) for 15.5 ± 10 months, 16 patients using the Y configuration Ultraset® (Baxter Healthcare Corp.) for 8.1 ± 5 months, and 6 patients using a universal adapter (Delmed Corp.) for 14.3 ± 7 months. Failure occurred in 7 cases (18%) at 12 ± 8 months using the O set (3 elective, 3 related to peritonitis, 1 ultrafiltration difficulty), and 1 (7%) at 3 months using the Ultraset (related to peritonitis). Accidental sodium hypochlorite infusion occurred 8 times in 6 patients, 4 patients still on CAPD without residual effect and 2 in whom infusion contributed to failure but not to ultrafiltration difficulty. Cumulative per-patient-year (episode/ months) peritonitis rates of 0.75 (1/16.4), 0.65 (1/18.4) and 0.88 (1/14.3), respectively, compare favorably with the overall center experience of 0.96 (1/12.2) (NIH-CAPD Registry). Peritonitis rates did not differ during use of any of the disconnect systems between patients with prior CAPD experience compared to patients without prior CAPD experience. More important, however, in patients with prior CAPD experience, peritonitis rates after initiation of the disconnect system tended to be lower than rates before disconnect with both the O set, 0.66 (1/18.1) vs. 1.18 (1/10.2) (n = 16, p < 0.09) and Ultraset, 0.46 (1/26.1) vs. 1.54 (1/7.9) (n = 6, p < 0.03), with insufficient data (n = 2) for the universal set. In conclusion, disconnect systems favorably influence not only patient preference for CAPD and ability to vary CAPD infusion volume, but also the frequency of peritonitis during long term use.


2001 ◽  
Vol 21 (3_suppl) ◽  
pp. 148-151 ◽  
Author(s):  
Börje Haraldsson

Computer models are valuable clinical tools in the effort to improve quality of life for dialysis patients. At present, two software programs have been validated clinically in adult and pediatric populations. They are the Personal Dialysis Capacity (PDC: Gambro Lundia AB, Lund, Sweden) and PD Adequest (Baxter Healthcare Corporation, Deerfield, IL, U.S.A.). Both programs seem to give accurate predictions of small-solute clearance, but the PDC seems to be superior in predicting ultrafiltration volumes. Indeed, the software programs have several important differences that affect their accuracy and, hence, their clinical value. The PDC software introduces the concepts of capillary physiology to the field of peritoneal dialysis. It gives a functional description of the peritoneal membrane of the individual patient. Recently, its “new” area parameter (A0/Δx) was shown to be superior to the peritoneal equilibration test (PET) in predicting transperitoneal exchange.


Sign in / Sign up

Export Citation Format

Share Document